Guardant Health Director Files Form 144 for Small Planned Sale
Guardant Health, Inc.
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Guardant Health, Inc. ($GH) Form 144 Filing Insider: Tariq Musa (Director) Shares to Sell: 116 Common Shares Estimated Value: $20,300.00 (~$175.00/share) Approx. Sale Date: 09/16/2026 Trading Plan: 10b5-1 plan adopted 12/17/2025 Significance: Low
Comprehensive Analysis
Executive Summary
On September 16, 2026, Tariq Musa, a Director at Guardant Health, Inc. ($GH), filed a Form 144 notice of proposed sale covering 116 common shares with an estimated aggregate market value of $20,300.00.
Transaction Details
- Filer: Tariq Musa (Director)
- Broker: Charles Schwab & Co., Inc.
- Securities Offered: 116 shares of Common Stock
- Aggregate Market Value: $20,300.00 (~$175.00 per share)
- Shares Outstanding: 134,196,170
- Approximate Date of Sale: September 16, 2026
- Acquisition Origin: Restricted Stock Lapse (Equity Compensation) on August 15, 2026
- Trading Plan: Adopted under Rule 10b5-1 on December 17, 2025
Prior 3-Month Sales
- 06/16/2026: 116 shares for $15,102.00
- 06/22/2026: 1,951 shares for $255,893.00
- 07/16/2026: 116 shares for $18,941.00
- 08/17/2026: 116 shares for $18,148.00
Market Impact & Significance
The transaction represents a negligible fraction of the company's 134.2 million shares outstanding. This proposed sale continues a routine pattern of monthly 116-share sales following equity vesting schedules and executed under a pre-established Rule 10b5-1 trading plan. Overall trading significance is Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.